Companies start 2019 in U.S. with price hikes on more than 250 prescription drugs
The overall number of price increases was down by around a third from last year, when drug-makers raised prices on more than 400 medicines, according to data provided by Rx Savings Solutions, which helps health plans and employers seek lower cost prescription medicines.
Allergan was particularly aggressive. It raised list prices on more than 50 drugs, and more than half of those by 9.5 percent, according to the Rx Savings data
AbbVie Inc. increased by 6.2 percent the list price of its blockbuster rheumatoid arthritis treatment Humira, which is on pace to record about $20 billion in sales in 2018. ■